Michael Mahoney is officially taking charge at Boston Scientific, becoming its CEO Thursday after a one-year stint as president at the medical device maker.
Mahoney’s transition period before becoming CEO skirted non-compete agreement with his previous employer, Johnson & Johnson. Mahoney had served as chairman of Johnson & Johnson’s medical device business. J&J has said the arrangement at Boston Scientific was appropriate.
